Home › Trial NCT03490344
Short Course Daratumumab in Patients With Multiple Myeloma
- Trial IDNCT03490344
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorMemorial Sloan Kettering Cancer Center
- Enrollment10
- Start date2018-05-03
- ConditionsMultiple Myeloma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.